AIM ImmunoTech Inc (AIM)
0.445
+0.04
(+9.93%)
USD |
NYAM |
May 06, 12:41
AIM ImmunoTech Gross Profit (TTM): 0.16M for Dec. 31, 2023
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 0.16M |
September 30, 2023 | 0.163M |
June 30, 2023 | 0.168M |
March 31, 2023 | 0.087M |
December 31, 2022 | -0.006M |
September 30, 2022 | -0.188M |
June 30, 2022 | -0.333M |
March 31, 2022 | -0.55M |
December 31, 2021 | -0.715M |
September 30, 2021 | -0.745M |
June 30, 2021 | -0.789M |
March 31, 2021 | -0.693M |
December 31, 2020 | -0.643M |
September 30, 2020 | -0.654M |
June 30, 2020 | -0.655M |
March 31, 2020 | -0.681M |
December 31, 2019 | -0.753M |
September 30, 2019 | -0.628M |
June 30, 2019 | -0.629M |
March 31, 2019 | -0.596M |
December 31, 2018 | -0.517M |
September 30, 2018 | -0.721M |
June 30, 2018 | -0.86M |
March 31, 2018 | -0.712M |
December 31, 2017 | -0.746M |
Date | Value |
---|---|
September 30, 2017 | -0.762M |
June 30, 2017 | -0.703M |
March 31, 2017 | -0.973M |
December 31, 2016 | -1.016M |
September 30, 2016 | -1.093M |
June 30, 2016 | -1.173M |
March 31, 2016 | -1.358M |
December 31, 2015 | -1.465M |
September 30, 2015 | -1.414M |
June 30, 2015 | -1.345M |
March 31, 2015 | -1.143M |
December 31, 2014 | -1.054M |
September 30, 2014 | -0.886M |
June 30, 2014 | -0.841M |
March 31, 2014 | -1.182M |
December 31, 2013 | -1.084M |
September 30, 2013 | -1.424M |
June 30, 2013 | -2.157M |
March 31, 2013 | -1.717M |
December 31, 2012 | -1.776M |
September 30, 2012 | -1.707M |
June 30, 2012 | -0.93M |
March 31, 2012 | -0.939M |
December 31, 2011 | -0.882M |
September 30, 2011 | -1.156M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
-0.789M
Minimum
Jun 2021
0.168M
Maximum
Jun 2023
-0.4255M
Average
-0.629M
Median
Jun 2019
Gross Profit (TTM) Benchmarks
Perspective Therapeutics Inc | -- |
Protalix BioTherapeutics Inc | 42.51M |
Electromed Inc | 39.55M |
Xtant Medical Holdings Inc | 55.47M |
Armata Pharmaceuticals Inc | -- |